Some people experience body aches or muscle pain , particularly during the first few weeks of treatment
This glucose dependency is a safety feature, making hypoglycemia rare
Many peptide therapy clinics prefer this concentration for exactly that reason
If you notice a rash that spreads, ongoing pain, or signs of infection (like warmth or swelling that gets worse), speak to your doctor

External resources PubMed - Search for "AOD 9604" or "tirzepatide" to access original research papers, systematic reviews, and clinical trial data from peer-reviewed journals ClinicalTrials.gov - Official registry of all ongoing and completed tirzepatide clinical trials including the full SURMOUNT and SURPASS programs FDA Drug Safety and Availability - Official safety communications, prescribing information, and regulatory updates for Mounjaro and Zepbound (tirzepatide) New England Journal of Medicine - Published the primary SURMOUNT-1 trial results and other landmark tirzepatide studies The Obesity Society - Evidence-based clinical guidelines and educational resources on pharmacological approaches to obesity management SeekPeptides provides calculators, protocol guides, and comparison tools that help users work through exactly these kinds of decisions with data rather than guesswork